Gene · 6300
Papers1,954
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,954
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nanostring Transcriptomic Analysis Highlights IL-6 Family and TGF-β Pathways in the Pathogenesis of Prurigo Nodularis. | JID Innov | 2026 | 41333131 | PubTator, text mining | PubMed |
| Advances in targeting p38 MAPK for cancer therapy: insights from molecular pharmacology and medicinal chemistry. | Mol Divers | 2026 | 40690115 | PubTator, text mining | PubMed |
| Long-term Survivors of Anaplastic Thyroid Cancer: A Genomic Predictive Model. | J Clin Endocrinol Metab | 2026 | 40663630 | PubTator, text mining | PubMed |
| The Novel Prognostic Biomarker MAPK12 Promotes Migration, Proliferation, and Invasion in Head and Neck Squamous Cell Carcinoma. | Curr Med Chem | 2025 | 42554336 | PubTator, text mining | PubMed |
MEK1/2 Inhibitor (U0126) and PI3K Inhibitor (LY294002) Suppress Herpes Simplex Virus Type 1 Replication by Targeting MAPK/ERK1/2 and PI3K/AKT Signaling Pathways: Implications for Oral Health and Translational Control of Orolabial HSV-1 Infection. | Iran J Pharm Res | 2025 | 41755994 | PubTator, text mining | PubMed |
| Identification of MAPK12 as a Prognostic Biomarker for Esophageal Carcinoma Using Bioinformatics and Machine Learning. | Biomed Res Int | 2025 | 41473739 | PubTator, text mining | PubMed |
| HMMR has oncoprotein-like properties in neuroblastoma cells and high HMMR expression has independent prognostic potential in neuroblastomas. | Sci Rep | 2025 | 41253884 | PubTator, text mining | PubMed |
| Retraction: Role of alterations in protein kinase p38γ in the pathogenesis of the synaptic pathology in dementia with Lewy bodies and α-synuclein transgenic models. | Front Neurosci | 2025 | 41189747 | PubTator, text mining | PubMed |
| Investigating the Roles of MAPKs as Precision Oncology Targets: A Multi-cancer Expression and Survival Study. | Cancer Genomics Proteomics | 2025 | 41151853 | PubTator, text mining | PubMed |
| The Impact of Gut Microbial Metabolomics on Type 2 Diabetes Development in People Living with HIV. | Metabolites | 2025 | 41003010 | PubTator, text mining | PubMed |
| Rational design of the linkers in targeting chimeras. | Chem Sci | 2025 | 40988686 | PubTator, text mining | PubMed |
| Olfactory receptors as tumor suppressors in cutaneous T-cell lymphoma via p38γ pathway modulation. | Blood Neoplasia | 2025 | 40979072 | PubTator, text mining | PubMed |
| Drug screening in 3D microtumors reveals DDR1/2-MAPK12-GLI1 as a vulnerability in cancer-associated fibroblasts. | Cell Rep Med | 2025 | 40975064 | PubTator, text mining | PubMed |
| The KRAS-G12D mutation drives venous thromboembolism (VTE) and colorectal cancer progression via MAPK/ERK signaling. | Transl Oncol | 2025 | 40972150 | PubTator, text mining | PubMed |
| Advances in ERK1/2 inhibition: a medicinal chemistry perspective on structure and regulation. | J Enzyme Inhib Med Chem | 2025 | 40928301 | PubTator, text mining | PubMed |
| The Role of MAPK12 in Prognosis of Patients With Liver Cancer and Effects on Stemness Characteristics. | Stem Cells Int | 2025 | 40909863 | PubTator, text mining | PubMed |
| Exploring the epigenetic modifications of the RONS-TRPA1-CGRP axis in migraine pathophysiology. | J Headache Pain | 2025 | 40890590 | PubTator, text mining | PubMed |
| Desmoglein-driven dynamic signaling in pemphigus vulgaris: a systematic review of pathogenic pathways. | NPJ Regen Med | 2025 | 40846710 | PubTator, text mining | PubMed |
| Phosphoproteome-derived peptide libraries for deep specificity profiling of phosphatases and phospholyases. | bioRxiv | 2025 | 40832327 | PubTator, text mining | PubMed |
| Gut-liver axis in diabetes: Mechanisms and therapeutic opportunities. | World J Gastroenterol | 2025 | 40809928 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6300/papers?page=2